Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Oxaliplatine USP Injection


Contraindicated
Reproductive toxicity in animals

Contraindicated
Manque de données
Oxaliplatine USP Injection :
Type Medicine Non Marketed
Originator Eloxatine 100mg*
Agent Major Pharma Drugstore
Distributor Major Pharma Drugstore
Laboratory Sagent
Responsible Party Sagent Pharmaceuticals Inc
Origin U.S.A.
Manufacturer Jiangsu Hengrui Medicine Co Ltd
Manufacturing Type G
Origin China
ATC L01XA03

Your comment will appear shortly after approval

Oxaliplatine USP Injection :

Revision Date : 20/01/2017


Effect Frequency
Abdominal pain Very Common
Allergic reaction Very Common
Allergy Very Common
Alopecia Very Common
Anaemia Very Common
Anorexia Very Common
Arthralgia (Pain joint) (Joint ache) Common
Asthenia Very Common
Back pain Very Common
Blindness transient (Temporary vision loss) Rare
Blood alkaline phosphatase increased Very Common
Blood lactate dehydrogenase increased Very Common
Bone pain Common
Cephalea Very Common
Colitis Rare
Conjunctivitis Common
Constipation Very Common
Cough Very Common
Creatinine increased Common
Deafness Rare
Deep vein thrombosis Common
Dehydration Common
Depression Common
Diarrhoea (Diarrhea) Very Common
Diarrhoea, Clostridium difficile Rare
Dizzy spells Common
Dysarthria Rare
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Very Common
Dyspepsia Common
Dyspnoea (dyspnea) Very Common
Dysuria (Micturition painful) Common
Epistaxis (Nasal bleeding) Very Common
Fatigue Very Common
Febrile neutropenia (Neutropenic fever) Common
Fever Very Common
Flushing Common
Gastrointestinal bleeding Common
Gastrooesophageal reflux disease Common
Haematuria (Hematuria) Common
Haemolytic anemia Rare
Haemorrhage Common
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) Common
Hepatic enzyme increased Very Common
Hiccups Common
Hyperglycaemia Very Common
Hyperhidrosis Common
Hypernatraemia Very Common
Hypertension Common
Hypokalaemia Very Common
Ileus Uncommon
Immune-mediated thrombocytopenia Rare
Infection Very Common
Injection site reaction Very Common
Insomnia Common
Interstitial pneumonia Rare
Intestinal obstruction Uncommon
Leucopenia (Leukopenia) Very Common
Lymphopenia Very Common
Meningism Common
Metabolic acidosis Uncommon
Mucositis Very Common
Nail disorders Common
Nausea postoperative Very Common
Nervousness Uncommon
Neuritis motor Common
Neutropenia Very Common
Neutropenic sepsis Common
Optic neuritis Rare
Ototoxicity Uncommon
Pain Very Common
Pancreatitis Rare
Peripheral sensory neuropathy Very Common
Posterior reversible leukoencephalopathy syndrome (PRES) Rare
Pulmonary embolism Common
Pulmonary fibrosis Rare
Rash erythematous Common
Rectal haemorrhage Common
Rhinitis Common
Sensory disturbance Very Common
Sepsis (Systemic infection) (Sepsis state) Uncommon
Serum bilirubin increased Very Common
Skin disorders Very Common
Skin rash Common
Stomatitis Very Common
Thrombocytopenia (Thrombopenia) Very Common
Upper respiratory tract infection Common
Urinary frequency altered Common
Visual acuity reduced Rare
Visual disturbance Common
Visual field defect Rare
Vomiting Very Common
Weight decreased (Weight loss) Common
Weight increased (weight gain) Very Common

Different Units By MoH Code

Oxaliplatine USP Injection  MoH 9210 :
Form Solution for infusion
Packaging Bottle
Package Size 1x20ml
Strength 100mg/20ml
NSSF ✘
Quarantine ✘
Reg. Number 152816/1
Submission date 01/01/2016
Registration Year 2017
Archived Date 03/05/2023


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info